| 000 | 01112 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250517163014.0 | ||
| 264 | 0 | _c20180913 | |
| 008 | 201809s 0 0 eng d | ||
| 022 | _a2213-8595 | ||
| 024 | 7 |
_a10.1016/S2213-8587(17)30184-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEastell, Richard | |
| 245 | 0 | 0 |
_aUse of bone turnover markers in postmenopausal osteoporosis. _h[electronic resource] |
| 260 |
_bThe lancet. Diabetes & endocrinology _c11 2017 |
||
| 300 |
_a908-923 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aBiomarkers _xmetabolism |
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBone Remodeling |
| 650 | 0 | 4 |
_aDiphosphonates _xtherapeutic use |
| 650 | 0 | 4 | _aFracture Healing |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOsteoporosis, Postmenopausal _xdiagnosis |
| 700 | 1 | _aSzulc, Pawel | |
| 773 | 0 |
_tThe lancet. Diabetes & endocrinology _gvol. 5 _gno. 11 _gp. 908-923 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S2213-8587(17)30184-5 _zAvailable from publisher's website |
| 999 |
_c27350319 _d27350319 |
||